MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer

Por Qi, Wenqing, Cooke, Larry S, Stejskal, Amy, Riley, Christopher, Croce, Kimiko Della, Saldanha, Jose W, Bearss, David, Mahadevan, Daruka
Publicado em 2009

The existence of Th22, pure Th17 and Th1 cells in CIN and Cervical Cancer along with their frequency variation in different stages of cervical cancer

Por Zhang, Wenjing, Tian, Xinli, Mumtahana, Fidia, Jiao, Jun, Zhang, Teng, Croce, Kimiko Della, Ma, Daoxin, Kong, Beihua, Cui, Baoxia
Publicado no BMC Cancer (2015)

Design and Activity of a Murine and Humanized anti-CEACAM6 scFv in the Treatment of Pancreatic Cancer

Por Riley, Christopher J., Engelhardt, Kevin P., Saldanha, Jose W., Qi, Wenqing, Cooke, Laurence S., Zhu, Yingting, Narayan, Satya T., Shakalya, Kishore, Croce, Kimiko Della, Georgiev, Ivan G., Nagle, Raymond B., Garewal, Harinder, Von Hoff, Daniel D., Mahadevan, Daruka
Publicado em 2009